semaglutide hemodialysis pharmacokinetics in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open‐label study - Vanek - 2024 - Diabetes, Obesity and Metabolism Is Ozempic (semaglutide) safe for

Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate

Whether those studies establish a sufficient benefit-risk profile for human use through compounding pharmacies was the core scientific question, and the committee's majority answered yes over the objections of FDA scientists who answered no

Even with a favorable advisory committee vote, the FDA requires formal rulemaking before compounding pharmacies can act

The WHO recently updated its policy, now recommending GLP-1 use in adults (excluding pregnancy) for the treatment of obesity, alongside lifestyle modifications like diet and exercise

However, its important to note that microdosing is not an FDA-approved use of these medications